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Shigella flexneri proliferate in infected human epithelial cells at
exceptionally high rates. This vigorous growth has important con-
sequences for rapid progression to life-threatening bloody diar-
rhea, but the underlying metabolic mechanisms remain poorly
understood. Here, we used metabolomics, proteomics, and genetic
experiments to determine host and Shigella metabolism during
infection in a cell culture model. The data suggest that infected
host cells maintain largely normal fluxes through glycolytic path-
ways, but the entire output of these pathways is captured by
Shigella, most likely in the form of pyruvate. This striking strategy
provides Shigella with an abundant favorable energy source,
while preserving host cell ATP generation, energy charge mainte-
nance, and survival, despite ongoing vigorous exploitation. Shi-
gella uses a simple three-step pathway to metabolize pyruvate
at high rates with acetate as an excreted waste product. The crucial
role of this pathway for Shigella intracellular growth suggests tar-
gets for antimicrobial chemotherapy of this devastating disease.
infectious diseases | host–pathogen interactions
Infectious diseases typically arise when pathogens grow to hightissue loads, causing extensive damage and immunopathology.
An outstanding example is Shigella flexneri, which rapidly grow
from a small infectious dose of 10–100 bacteria (1) to intestinal
loads causing life-threatening bloody diarrhea (bacillary dysen-
tery) within a few hours (2, 3). This vigorous Shigella growth
occurs inside human colon epithelial cells and requires an in-
tegrated Shigella pathogenesis program, including a type three
secretion system encoded on the Shigella virulence plasmid.
Using this system, Shigella translocates enzymes into the host cell
cytosol, where they target key cellular functions, allowing Shigella
to enter the host cell and escape bacterial killing by innate im-
mune responses (4). After Shigella reaches the host cell cytosol,
many virulence factors are down-regulated (5), and Shigella starts
rapid proliferation.
Biomass generation at such high rates depends on extensive
exploitation of intracellular host nutrients (6). The host cell cy-
toplasm contains hundreds of metabolites, but it is unclear which
of these potential nutrients Shigella uses, how the host cell can
supply them at sufficiently high rates to support rapid Shigella
growth, and why host cells can sustain viability while being vig-
orously exploited by intracellular Shigella. For related enter-
oinvasive Escherichia coli, previous research has shown that
glucose and other host metabolites, such as diverse amino acids,
can be incorporated into the biomass of these closely related
pathogens (7). However, quantitative data are still lacking, and
energy production, which is usually a major part of nutrient use (8),
could not be analyzed because of technical limitations.
In general, pathogen metabolism has been recognized as a fun-
damentally important aspect of infectious diseases, but available
data are mostly restricted to qualitative presence/absence of enzymes
in pathogen genomes and metabolite or gene expression profiles
in various infection models (9–13). Comprehensive quantitative
studies on pathogen nutrition, metabolism, and growth are largely
lacking. This limited knowledge reflects, in part, the fact that suit-
able methodologies are just becoming available. In this study, we
combined various metabolomics approaches, proteomics, and mi-
crobial genetics to elucidate the metabolic basis of Shigella rapid
growth in infected human host cells.
Results
Shigella Grow Rapidly Inside HeLa Host Cells. We infected HeLa
epithelial cells with S. flexneri 2a 2457T icsA. The icsA mutation
prevents spread between host cells (14, 15), thereby simplifying
analysis of intracellular growth. In this model, Shigella grew
rapidly with a generation time of 37 ± 4 min (Fig. S1 and Movie
S1), close to maximal axenic growth rates in rich broth and faster
than almost all other pathogens in their respective host envi-
ronments. Infected HeLa cells remained intact until around 3.5–
4 h postinfection, when their cytoplasm was packed with more
than 100 Shigella. The HeLa cells subsequently detached and
disintegrated, which was observed previously (16).
Host Central Metabolism Remains Functional During Shigella Infection.
Rapid intracellular Shigella growth likely causes a substantial
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metabolic burden on the infected host cell. Metabolite quantifica-
tion in infected and uninfected cells identified some metabolites
with differential concentrations (Tables S1 and S2), but surpris-
ingly, the energy charge, a measurement of relative ATP, ADP, and
AMP levels, did not change significantly on infection (uninfected
cells, 0.83 ± 0.03; infected cells, 0.80 ± 0.05). This observation
showed that infected cells largely maintain their energy production,
despite ongoing exploitation by Shigella.
Quantitative metabolite analyses of pathogen-infected host
cells encounter the general technical challenge that pathogen
and host cell contents are not easily separable within the re-
quired time frame. Available separation techniques would in-
evitably cause a time delay of up to minutes, during which rapid
reactions, such as ATP hydrolysis, would substantially alter me-
tabolite concentrations. To avoid such artifacts, we quenched the
cell culture immediately and determined combined metabolite
concentrations from infected cells and Shigella. Because of the
much larger volume of human cells compared with Shigella, most
of these data are probably dominated by host metabolites. As
an example, we experimentally determined Shigella adenosine
phosphate (AXP) contents in various axenic cultures (glucose or
pyruvate as sole energy/carbon source provided at 0.1 or 1 g L−1).
The results showed that 50 Shigella cells contained 0.25–0.69
fmol ATP, 0.19–0.35 fmol ADP, and 0.04–0.05 fmol AMP. Even
when subtracting these potential Shigella contributions from the
combined AXP levels of infected HeLa cells, the HeLa-only
AXP values would still yield an energy charge of 0.79 ± 0.02,
suggesting a very minor impact of Shigella AXP on calculated
host cell energy charge values, which was expected based on the
different cell volumes of HeLa and Shigella.
Various mechanisms could enable infected host cells to
maintain their energy charge, despite Shigella exploitation. In
particular, infected cells might increase nutrient uptake from the
extracellular environment (17). However, under the experimen-
tal conditions used here, uninfected and infected cells consumed
glucose at similar rates (9.0 ± 1.1 vs. 9.3 ± 1.3 fmol/min per cell),
whereas uptake of glutamine, another potentially major nutrient
for mammalian cells, remained below 0.5 fmol/min per cell.
To determine metabolic fluxes involved in host cell ATP
production, we switched unlabeled glucose in the external me-
dium to uniformly labeled (U-) 13C glucose and monitored sub-
sequent 13C incorporation in diverse metabolites using mass
spectrometry (MS) (Fig. 1A and Table S3). Uninfected HeLa
cells showed uptake and catabolism of glucose through Embden–
Meyerhof and pentose phosphate pathways but very little feeding
into tricarboxylic acid (TCA) cycle intermediates, indicating
predominant ATP generation through fermentation, which was
previously shown for HeLa and other cancer cell lines (18, 19).
Interestingly, infected HeLa cells, which contained around 50
rapidly growing Shigella at 2.5 h postinfection, had almost
Fig. 1. (A) 13C-incorporation kinetics for various metabolites in uninfected (blue) or infected (red) HeLa cells after feeding of U-13C glucose. The 13C-labeling
percentage is calculated as the fraction of the labeled species (2-13C for acetyl-CoA and U-13C for others) relative to the total metabolite pool. Data are
represent means and SDs of six independent experiments (Table S3 shows the full dataset). (B) Extracellular metabolites before (black) and 3 h after (red)
infection as detected by 1D 1H NMR (Fig. S3 shows identification of acetate by 2D [13C,1H] NMR). Uninfected HeLa cells are shown for comparison (blue). The
medium contained U-13C glucose. (C) 13C labeling of extracellular acetate in medium containing U-13C–labeled compounds (glc*, glucose; gln*, glutamine) or
unlabeled compounds (glc, glucose; gln, glutamine). Data represent means and SDs of three independent experiments. (D) Overview of 13C labeling of
metabolites from U-13C glucose in infected HeLa cells. Font color and superscripts indicate the percentage of the labeled species (2-13C for acetyl-CoA and
U-13C for others) after 20 min (all intracellular metabolites) or 1 h (acetate) of feeding with 13C glucose. Data represent means from six independent
experiments. PPP, pentose phosphate pathway and related metabolites.
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identical label incorporation kinetics in Embden–Meyerhof and
pentose phosphate pathway intermediates and marginal flux into
the TCA cycle. This flux distribution suggested that host cells
maintained their energy charge during infection by using the
main preexisting energy-producing glycolytic pathways. Pro-
teome comparisons revealed that, in general, host cell enzyme
abundance changed little during infection (Fig. S2), arguing
against a major reorganization of the host metabolic network
during infection. This proteomics result was consistent with
previous data on unaltered host cell amino acid biosynthesis
during infection with related enteroinvasive E. coli (7).
Infection Reroutes Carbon Flux to Acetate Excretion. The apparently
minor impact of infection on central host metabolism was sur-
prising, because Shigella obviously must redirect major metabolic
fluxes and capture abundant metabolites to sustain its rapid
proliferation. Indeed, our 13C glucose isotope-tracking experi-
ments showed one remarkable difference between infected and
uninfected cells: a substantial fraction (56 ± 11%) of the acetyl
moiety in acetyl-CoA was rapidly labeled exclusively in infected
cells (Fig. 1A and Table S3). Interestingly, this 13C was hardly
transferred to TCA cycle intermediates, suggesting metabo-
lization through other pathways. To identify potential end
products, we analyzed metabolites in the cell culture medium by
NMR spectroscopy. Uninfected cells converted glucose to lac-
tate and pyruvate (Figs. 1B and 2A), which was expected for this
cell line (20). Surprisingly, lactate and pyruvate excretion was
completely abolished in Shigella-infected cells (Figs. 1B and 2A).
Instead, these cells excreted acetate at a ratio of 2.1 ± 0.3 acetate
per consumed glucose (Figs. 1B and 2A and Fig. S2, identifica-
tion of acetate by NMR). Experiments using media containing
13C glucose or 13C glutamine showed that most acetate originated
from glucose but not glutamine (Fig. 1C).
Together, these data showed that, in infected cells, the dom-
inant glycolytic pathways were fully functional but that their
entire output was rerouted to acetate (Fig. 1D). This finding was
in marked contrast to Shigella-infected macrophages that be-
come metabolically inactive and rapidly die (21) because of
IpaB-mediated pyroptosis (22).
Shigella Produces Acetate from Pyruvate. Acetate is the dominant
waste product of rapidly growing Enterobacteriaceae, such as
Shigella and E. coli (23). Specifically, Shigella uses phospho-
transacetylase (PTA) to convert acetyl-CoA to acetyl phosphate
and acetate kinase (ACKA) to convert acetyl phosphate and
ADP to acetate and ATP. To test the role of this Shigella acetate-
generating pathway during infection, we constructed Shigella pta
and ackA mutants. Both Shigella mutants had substantial in-
tracellular growth defects (40–60% of parental strain) (Fig. 2B
and Table S4). Complementation of the pta mutant with an
episomal pta allele rescued normal growth, indicating that the
Shigella pta phenotype was caused by the deletion of pta. The
reduced mutant growth rates resulted in strongly diminished
Shigella loads after 3.5 h of infection (13 ± 2 Shigella pta and 8 ±
1 Shigella ackA per HeLa cell vs. 73 ± 9 parental Shigella),
consistent with longer generation times. Over an entire day of
infection, these longer generation times could lead to some
500,000-fold lower Shigella loads for mutants vs. the parental
strain (assuming continuous growth). These data show that the
acetate pathway is active and essential for normal Shigella in-
tracellular growth. Similar data for polarized Caco-2 cells and
human umbilical vein endothelial cells (HUVECs) (Table S4)
suggested analogous Shigella metabolic strategies in a colon ep-
ithelial cell line as well as primary human cells.
HeLa cells infected with Shigella pta or ackA excreted lactate
and pyruvate but very little acetate (Fig. 2A). These data sug-
gested that most of the acetate excreted from HeLa cells that
were infected with the Shigella parental strain was a product of
Shigella pyruvate to acetate conversion, which largely depends on
a functional PTA–ACKA pathway (23). The low residual acetate
production of cells infected with Shigella pta or ackA mutants
could reflect alternative Shigella pathways [such as pyruvate
oxidation mediated by pyruvate oxidase (POXB)] or host cell
activities (23). HeLa cells incubated together with gentamicin-
killed Shigella excreted no acetate, again consistent with acetate
as a product of Shigella metabolism.
Together, these data suggest that infected cells switched from
lactate excretion to acetate excretion as a result of Shigella cap-
turing host metabolites and converting them to acetate primarily
through the PTA–ACKA pathway.
Pyruvate Is Taken Up by Shigella from the Host Cytosol. To de-
termine potential host metabolites that fuel Shigella acetate gen-
eration, we mutated additional metabolic genes. Shigella aceE
deficient for pyruvate dehydrogenase and thus, impaired in con-
version of pyruvate to acetyl-CoA showed a strong growth defect
and largely abolished acetate production, suggesting that pyruvate
was a major source of acetyl-CoA and acetate in Shigella (Fig.
2B and Table S4).
Fig. 2. (A) Net metabolite excretion of uninfected HeLa cells and HeLa cells
infected with various Shigella strains between 2 and 3 h postinfection de-
termined by NMR spectroscopy. Data represent means and SDs of three in-
dependent experiments. (B) Intracellular generation time of Shigellamutant
strains (μmut) relative to the parental strain (μpar; pta/pPTA, Shigella pta
mutant complemented in trans with an episomal pta allele). A value of 1.0
(dashed line) corresponds to unimpaired growth. Data represent means and
SDs of 34–56 replicate wells. Detailed data and statistical analysis are in
Table S4. (C) 13C labeling of extracellular acetate in medium containing
U-13C–labeled compounds (glc*, 25 mM glucose; pyr*, 5 mM pyruvate) or
unlabeled compounds (glc, 25 mM glucose; pyr, 5 mM pyruvate). Data
represent means and SDs of three independent experiments. (D)
13C-incorporation kinetics of acetyl-CoA, phosphoenolpyruvate, and citrate
in infected HeLa cells after feeding U-13C pyruvate in the presence of
a fivefold excess of unlabeled glucose. Labeling percentage refers to the
fraction of 2-13C (acetyl-CoA) or U-13C (PEP and citrate) metabolite relative to
the total metabolite pool. Data represent means and SDs of three in-
dependent experiments (full dataset is in Table S5).
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Shigella could obtain this pyruvate directly from the host cell
cytoplasm or generate it itself from other host cell metabolites
through glycolysis and/or lactate oxidation. A Shigella manXYZ
galP ptsG mglBAC uhpT mutant unable to use glucose and
mannose as well as hexose phosphates exhibited unimpaired
growth (Fig. 2B and Table S4). A pykA pykF ptsI mutant de-
fective for the last step of glycolysis [conversion of phospho-
enolpyruvate (PEP) to pyruvate], which cannot grow on any
glycolysis intermediate upstream of pyruvate in vitro, had
a moderate growth defect (77 ± 10% of the parental strain’s
intracellular growth rate) (Fig. 2B and Table S4). These data
indicated the importance of the PEP–pyruvate conversion but
also showed substantial growth of Shigella, even without the use
of any host glycolysis intermediate. This mutant phenotype was
consistent with unabated 13C-label incorporation in host cell
metabolites from hexose phosphate all of the way down to py-
ruvate, suggesting at most, minor consumption of host cell
intermediates upstream of pyruvate by Shigella. These data are in
agreement with previous studies showing no growth of closely
related E. coli on key glycolysis intermediates 3-phosphoglycerate,
2-phosphoglycerate, and phosphoenolpyruvate (24), and toxic
effects of excessive uptake of organophosphates (25). Finally,
Shigella ldhA lldD incapable of lactate utilization also maintained
normal growth, arguing against lactate as a critical source of py-
ruvate (Fig. 2B and Table S4). Taken together, these data suggested
direct uptake of pyruvate by Shigella from the host cell cytoplasm as
the main supply route. A major role of pyruvate and its apparently
complete conversion into acetate was also consistent with the fact
that pyruvate (oxidation state +2) is a highly acetogenic substrate
compared with nutrients with a lower oxidation state, such as glu-
cose (23).
Initially, it was surprising that just a few Shigella cells could
apparently capture the entire glycolysis output of much larger
HeLa cells. However, Shigella can efficiently use external pyru-
vate as a sole carbon and energy source. Indeed, NMR spec-
troscopy revealed that Shigella consumed pyruvate in vitro at a rate
of 0.35 ± 0.06 fmol min−1 per Shigella in M9 minimal medium
containing 1 mM pyruvate and nicotinic acid and 0.1% tryptic soy
broth as supplements. Based on these data, some 50 Shigella can
indeed consume all pyruvate generated by host metabolism in an
infected HeLa cell (around 20 fmol min−1; see above).
Direct validation of Shigella pyruvate uptake during in-
tracellular growth would require a mutant with blocked pyruvate
uptake. Unfortunately, several yet unidentified high-affinity py-
ruvate transporters exist in Shigella/E. coli (26). We deleted
multiple tentative candidates [yhjE (27); actP, a homolog ofmctC
(28); ycaM and ybaT, putative transporter genes up-regulated in
E. coli on pyruvate-containing media (29)], but the resulting
combination mutant was still able to grow rapidly on pyruvate in
vitro, showing the presence of other yet unidentified pyruvate
import mechanisms.
As an alternative approach, we added 13C pyruvate to the
external medium of infected HeLa cells and tracked the labeled
carbon. NMR analysis of the extracellular medium revealed
efficient conversion of 13C pyruvate to 13C acetate, even in the
presence of an excess of unlabeled glucose (Fig. 2C), consistent
with preferred use of pyruvate over glucose and glycolysis
pathway intermediates. Indeed, the only detectable intracellular
metabolite that rapidly acquired substantial amounts of 13C in
infected cells was acetyl-CoA, whereas directly adjacent metab-
olites PEP and citrate were not labeled or labeled at much lower
rate (Fig. 2D and Table S5). Their poor labeling rules out
Embden–Meyerhof and pentose phosphate pathways or TCA
cycle intermediates as relevant sources of the strongly labeled
excreted acetate and supports a direct conversion of host-derived
pyruvate to acetyl-CoA and acetate by Shigella.
Together, these data suggest major Shigella nutrient use through
a short pathway: pyruvate (host cytoplasm)→ pyruvate (Shigella)→
acetyl-CoA (Shigella) → acetyl-phosphate (Shigella) → acetate
(Shigella)→ acetate (host cytoplasm)→ acetate (medium) (Fig. 3).
For each pyruvate molecule, this pathway yields one ATP in the
conversion of acetyl-phosphate to acetate. Because one molecule of
glucose is essentially fully converted into two excreted acetate
molecules, this pathway predominantly provides energy, but not
carbon, for Shigella growth. The limited role of pyruvate as a car-
bon source might explain why this major pathway escaped de-
tection in previous metabolic studies of related pathogens using
methods focusing on pathogen biomass incorporation (10).
Intracellular Shigella Consume Oxygen by Respiration. Oxidation of
glucose to pyruvate and pyruvate to acetate yields reducing
equivalents that might, in part, be used for Shigella biosynthetic
pathways, such as lipogenesis. In addition, infected cells con-
sumed oxygen at a rate of 0.07 ± 0.02 fmol/min per Shigella,
whereas uninfected cells had undetectable oxygen consumption
in our assay. This oxygen consumption was mostly caused by
Shigella respiration, because cells infected with Shigella ubiC
menA (lacking ubiquinone and menaquinone required for aer-
obic respiration) consumed much less oxygen (0.003 ± 0.001
fmol/min per Shigella). This observation is consistent with com-
monly observed active respiration during acetate production in
Enterobacteriaceae (23). Additional work is required to identify
which of the many potential intermediate electron donors/
acceptors are involved in the various host and Shigella redox
reactions.
Additional Nutrients Support Shigella Growth. In addition to the
major energy source pyruvate, Shigellamight obtain other nutrients
from the host cell cytoplasm to meet its biomass demands. We
analyzed Shigella mutants with utilization defects for 18 diverse
metabolites that are known to be available in human cell cyto-
plasm (30). However, all mutants except one had growth rates
indistinguishable from the parental strain (Tables S6 and S7). The
weak but significant growth defect of fadD fadK suggests a po-
tential small contribution of host fatty acids to Shigella growth. We
also analyzed growth phenotypes of 11 auxotrophic Shigella
mutants that depend on external supplementation of specific
nutrients for growth (Tables S6 and S7). High intracellular
growth rates of these auxotrophs showed Shigella access to di-
verse amino acids in sufficient amounts to fully meet their re-
spective Shigella biomass needs, which was previously observed
for closely related pathogens (10). Asparagine, proline, and
purine nucleosides were also available but only in limiting
amounts, requiring additional Shigella biosynthesis for full
Fig. 3. Metabolic overview of Shigella-infected HeLa cells. Uninfected cells
(blue) convert glucose to lactate. In infected cells (red), Shigella takes up
glucose-derived pyruvate from the host cytoplasm and converts it to acetate,
which is excreted into the environment. In addition, Shigella uses host fatty
acids, amino acids, and purine nucleosides. Thick and thin arrows indicate
major and minor carbon flux routes, respectively. The dashed arrows rep-
resent reactions not supported by available evidence.
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growth. Availability of these (and possibly, additional) diverse
nutrients represented another important contribution to support
vigorous intracellular Shigella growth. However, compared with the
massive throughput of pyruvate use, uptake of additional nutrients
for Shigella biomass production must be rather low: based on ac-
etate excretion, each Shigella consumed, on average, 1.2 pg pyru-
vate but generated total new biomass of only 0.4 pg (31) within one
generation time (37 min).
We incorporated our data for Shigella pyruvate consumption,
respiration, and additional biomass supplementation in an in
silico genome-scale metabolic model of closely related E. coli
(32). According to this model, the measured fluxes would enable
Shigella growth with generation times in the range of 33–54 min
(based on error margins of the underlying experimental data),
which is in good agreement with our experimentally determined
generation time of 37 ± 4 min, showing that nutrients identified
in this study can largely explain the outstandingly rapid in-
tracellular Shigella growth as one precondition for the rapid and
dramatic disease progression in dysentery.
Discussion
Rapid disease progression in bacillary dysentery is the result of
vigorous Shigella growth in gut epithelial cells. In addition to
a large number of virulence factors that interfere with host sig-
naling networks, this fast growth requires massive Shigella ex-
ploitation of host metabolism for high-flux nutrient supply.
However, infected cells remain viable for several hours until they
contain more than 100 bacteria. In this study, we show that Shigella
does not affect the main host cell energy production pathways—
Embden–Meyerhof and pentose phosphate pathways—but in-
stead, consumes their entire output at the level of pyruvate. For
this purpose, Shigella uses a short pyruvate-to-acetate pathway
that Enterobacteriaceae typically use during rapid growth under
nutrient-rich conditions (23). S. flexneri cannot reuse acetate later,
because it lacks acetyl-CoA synthetase that is present in closely
related E. coli (33).
This pathway generates only a single ATP for each pyruvate
molecule (and some additional ATP through oxidation of NADH),
and it is far less efficient in terms of ATP generation compared
with the TCA cycle (up to 14 ATP per pyruvate) that predom-
inates under nutrient-poor conditions. However, the low-yield
acetate pathway has lower enzyme costs and membrane space
requirements and can operate at much faster rates compared with
low-throughput, high-yield TCA cycle/oxidative phosphorylation,
which requires bulky enzymatic machinery in the bacterial inner
membrane. The acetate pathway can, thus, cope with high nutrient
supply rates that would saturate the respiratory chain (overflow
metabolism) (34). Similar switches to low-yield/high-rate pathways
are observed for many microbial cells (Crabtree effect) (23) as well
as cancer cells (Warburg effect) (20) during rapid growth.
The use of abundant pyruvate predominantly through this low-
yield, high-speed acetate pathway represents a typical metabolic
pattern of Enterobacteriaceae in general (23). Interestingly, this
default pathway could offer several additional important benefits
to Shigella during intracellular growth in infected human cells: (i)
use of a favorable abundant energy source, pyruvate, at high
rates; (ii) exploitation of the dominant preexisting host meta-
bolic pathways as high-flux supply lines without requiring major
host cell metabolism alterations that could cause delays and limit
supply; and (iii) preservation of host cell energy charge by gly-
colytic ATP generation, allowing extended host cell survival,
despite vigorous exploitation. Taken together, a short metabolic
pathway that is commonly present in many bacteria enables
Shigella to efficiently exploit major nutrient supply routes in
infected host cells. This preadaptation might explain why Shigella
can thrive as a voracious pathogen with only minor metabolic
adaptations to the host cell intracellular environment compared
with closely related extracellular commensals (33, 35). In addition
to the major energy source pyruvate, Shigella accessed diverse
host metabolites for direct biomass incorporation. Computational
modeling revealed that all these nutrients together were sufficient
to support the experimentally observed rapid Shigella intra-
cellular growth.
An important caveat of our study was the use of cancer cell
lines as host cells that ferment glucose to lactate to satisfy their
energy needs (the Warburg effect). Dysentery is a disease of the
colon, and the epithelial cells in this location, the colonocytes,
have a different metabolism. Some 80% of ATP produced in
colonocytes comes from mitochondrial oxidation of butyrate,
which is derived from gut microbiota. However, experiments with
germ-free mice have shown that, in the absence of microbiota-
derived butyrate, colonocytes switch from burning butyrate to
fermenting glucose to lactate (36). It is possible that the flushing
action of diarrhea during dysentery removes much of the micro-
biota, thereby lowering butyrate levels in the colon and triggering
colonocyte metabolism similar to HeLa cell metabolism in our in
vitro model. Additional studies are required to clarify this issue.
Comprehensive quantitative data on pathogen nutrition, me-
tabolism, and growth in host environments are largely lacking.
However, comparison of the Shigella data with our recent study on
Salmonella enterica metabolism in a mouse typhoid fever model
(37) reveals commonalities and striking differences. Shigella, like
Salmonella and many other pathogens (37), exploits the fact that
most biomass components are readily available in infected host
environments. Uptake of these biomass components can save
substantial biosynthesis costs. However, Shigella has access to
a high-flux supply for pyruvate that provides sufficient energy
to drive fast growth, whereas intracellular Salmonella has access
to many diverse but only scarce energy sources that together just
support slow nutrient-limited growth (37). This striking difference
may reflect the fact that Shigella reside directly in the host cyto-
plasm, whereas intracellular Salmonella are surrounded by
a phagosomal membrane with apparently poor permeability in
macrophages (their main target cell type during systemic infec-
tions). Additional studies with other pathogens might clarify the
general relevance of these distinct metabolic patterns.
Although host pyruvate supply enables vigorous Shigella pro-
liferation, the heavy dependence on pyruvate metabolism makes
Shigella also vulnerable to metabolic perturbation. Indeed, our
mutant data for the corresponding enzymes show dramatically
reduced Shigella loads compared with the parental strain, even
within short infection times. The residual slow growth of these
mutants and their altered waste product spectrum show that
Shigella can use alternative pathways, such as pyruvate oxidase,
but these pathways are far less efficient for supporting growth
as expected (23). Importantly, the key enzymes phospho-
transacetylase (PTA) and acetate kinase (ACKA) have no
human homologs, suggesting that specific inhibition of Shigella
enzymes without adverse effects on human metabolism might be
possible. Shigella acetate metabolism enzymes could, thus, rep-
resent promising targets to control bacillary dysentery.
Materials and Methods
Strains and Plasmids. HeLa Kyoto cells (38) and HUVECs were provided by
Cécile Arrieumerlou and Claudia Mistl (Biozentrum, University of Basel).
Caco-2 cells (ATCC-HTB-37) were obtained from the American Type Culture
Collection. S. flexneri 2a 2457T icsA was provided by M. B. Goldberg (Mas-
sachusetts General Hospital, Boston). All mutants in this work were derived
from this icsA strain (referred to as the parental strain). Mutants were
constructed as described (39) using a λ-red recombinase-mediated allelic
replacement system introducing a flippase recognition target sites-flanked
chloramphenicol resistance marker (40) followed by purification using
phage P1 transduction. Combinations of multiple deletions were made by P1
transduction into mutants, in which the chloramphenicol resistance was
removed using flippase. For complementation of the pta mutant, we cloned
pta together with its native promoter (intergenic region upstream of the
ackA-pta operon) on a medium copy number plasmid (pA15 ori). All strains
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carried plasmid pNF106 (SC101 ori) for doxycycline/anhydrotetracycline-
inducible expression of gfp (39).
Labeled Nutrients. [U-99% 13C]-labeled glucose, [U-99% 13C;U-99% 15N]-labeled
glutamine, and [U-99% 13C]-labeled pyruvate were purchased from Cambridge
Isotopes Laboratories.
Shigella Infections. HeLa cells, CaCo-2 cells, and HUVECs were infected with
polylysine-treated Shigella. After 30 min, cells were washed and treated
with gentamicin. Intracellular growth of GFP-expressing Shigella was de-
termined using flow cytometry and plating. Protocols for infections and
growth determination are described in detail in SI Materials and Methods.
Proteomics of Infected Cells. Cells were harvested, digested with trypsin/
chymotrypsin, and analyzed by MS as described in SI Materials and Methods.
Measurement of Intracellular Metabolites by MS. Uninfected and infected cells
were quenched with acetonitrile/methanol/formic acid. Samples were ana-
lyzed by MS. Detailed protocols are described in SI Materials and Methods.
Measurement of Glucose Uptake Rates. Glucose consumption was determined
using the EnzyChrom Glucose Assay Kit (Bioassay Systems) as described in SI
Materials and Methods.
Measurement of Excreted Extracellular Metabolites. Supernatants of un-
infected and infected cells were analyzed by 1D 1H NMR spectroscopy as
described in SI Materials and Methods.
Oxygen Consumption Measurements. Oxygen consumption of infected and
uninfected cells was determined using Oxoplates (OP96C; PreSens) and a
fluorescent plate reader as described in SI Materials and Methods.
Modeling of Intracellular Shigella Metabolism. Experimental metabolite up-
take rates and mutant phenotypes were combined with a modified E. coli
metabolism reconstruction (32) to model intracellular Shigella metabolism
using Flux-Balance Analysis as described in SI Materials and Methods.
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